iPSC biotech Shoreline Biosciences wins patent infringement suit over Fate, Whitehead Institute
The US District Court for the Southern District of California ruled last week in favor of San Diego-based Shoreline Biosciences, rejecting arguments from Fate Therapeutics and the Whitehead Institute for Biomedical Research after they filed a patent infringement suit against the biotech last year.
Judge Marilyn Huff granted Shoreline’s request for summary judgment on Aug. 31, denying Fate and Whitehead’s request for partial summary judgment.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.